Heartflow (NASDAQ:HTFL) & Evolent Health (NYSE:EVH) Head-To-Head Contrast

Heartflow (NASDAQ:HTFL) and Evolent Health (NYSE:EVH) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, dividends, analyst recommendations, institutional ownership, valuation and profitability.

Volatility & Risk

Heartflow has a beta of 2.5, indicating that its share price is 150% more volatile than the S&P 500. Comparatively, Evolent Health has a beta of 1.03, indicating that its share price is 3% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and price targets for Heartflow and Evolent Health, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heartflow	1	2	8	1	2.75
Evolent Health	1	3	11	0	2.67

Heartflow currently has a consensus target price of $48.62, indicating a potential downside of 18.54%. Evolent Health has a consensus target price of $6.11, indicating a potential upside of 30.36%. Given Evolent Health’s higher possible upside, analysts clearly believe Evolent Health is more favorable than Heartflow.

Profitability

This table compares Heartflow and Evolent Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Heartflow	-55.82%	-23.52%	-18.66%
Evolent Health	-21.67%	-6.07%	-1.23%

Valuation and Earnings

This table compares Heartflow and Evolent Health”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heartflow	$212.07 million	24.47	-$116.79 million	($1.83)	-32.62
Evolent Health	$1.88 billion	0.28	-$534.51 million	($4.54)	-1.03

Heartflow has higher earnings, but lower revenue than Evolent Health. Heartflow is trading at a lower price-to-earnings ratio than Evolent Health, indicating that it is currently the more affordable of the two stocks.

Summary

Evolent Health beats Heartflow on 7 of the 13 factors compared between the two stocks.

About Heartflow

HeartFlow, Inc. is a medical technology company that develops noninvasive tools to help clinicians assess coronary artery disease. Its platform analyzes coronary CT angiography scans to create personalized models of a patient’s coronary arteries and provide information that can support diagnosis and treatment planning. The company’s offerings include HeartFlow FFR CT Analysis, which estimates blood flow and the effects of artery narrowing, and tools for assessing coronary plaque. The technology combines medical imaging with computational analysis and artificial intelligence, giving clinicians information without requiring an invasive procedure to measure blood flow.

About Evolent Health

Evolent Health, Inc. provides technology-enabled services to health plans and healthcare providers in the United States. The company helps clients manage care, coordinate services and support the delivery of healthcare, particularly for people with complex medical needs. Its offerings include specialty care management programs, clinical and administrative services, and technology that supports care decisions and operations. Evolent has focused on areas such as oncology, cardiology, musculoskeletal care and behavioral health.